Literature DB >> 23928339

Impact of transseptal puncture site on acute and mid-term outcomes during cryoballoon ablation: a comparison between anterior, medial and posterior transatrial access.

Gian-Battista Chierchia1, Ruben Casado-Arroyo, Carlo de Asmundis, Moises Rodriguez-Manero, Andrea Sarkozy, Giulio Conte, Juan Sieira, Moises Levinstein, Giannis Baltogiannis, Giacomo di Giovanni, Ingrid Overeinder, Salvatore Ocello, Eligio Rosas, Francesco Isola, Pedro Brugada.   

Abstract

BACKGROUND: Cryoballoon ablation (CBA) (Arctic Front, Medtronic, USA) has proven very effective in achieving pulmonary vein isolation (PVI). Different transseptal (TS) puncture sites might influence CBA procedure. The aim of the present study was to analyze the influence of different TS puncture sites (anterior, medial and posterior) on the acute and midterm outcomes of CBA in a series of patients undergoing PVI for drug resistant AF. METHODS AND
RESULTS: A total 103 patients (78 males, mean age: 57 ± 13 years) formed the study group. Transseptal punctures were performed in the anterior, medial and posterior portion of the FO in 41 (39.8%), 35 (34%) and 27 (26.2%) patients respectively. We found no statistical significant difference between the various sites of TS puncture in 1) the grade of PV occlusion (p = ns), the rate of PV isolation (p = ns), freedom from AF at a mean 12 month follow-up (p = ns) and complication rates (p = ns). Mean grade of occlusion was slightly lower in the RIPV when puncturing in the posterior FO but did not reach statistical significance. Mean procedural and fluoroscopy times were significantly lower when using the inner lumen mapping catheter (ILMC) (Achieve, Medtronic, USA) than the circular mapping catheter (CMC) (Lasso, Biosense Webster, California, USA) (107.24 mn vs 97.74 (p ≤ 0.001) and 25.7 mn vs 19.2 mn (p ≤ 0.001)).
CONCLUSION: Different sites of TS puncture on the horizontal axis of the FO (anterior, medial and posterior) did not influence grades of PV occlusion, rates of isolation, mid-term outcome and rates of complications during CB ablation.
© 2013.

Entities:  

Keywords:  Atrial fibrillation; Cryoballoon; Transseptal puncture

Mesh:

Year:  2013        PMID: 23928339     DOI: 10.1016/j.ijcard.2013.07.079

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Prospective evaluation of iatrogenic atrial septal defect after cryoballoon or radiofrequency catheter ablation of atrial fibrillation-"EVITA" study.

Authors:  Zsofia Nagy; Zsuzsanna Kis; Tamás Géczy; Andras Temesvari; Zoltan Som; Sarolta Borbas; Tamás Breuer; David Molnar; Csaba Foldesi; Attila Kardos
Journal:  J Interv Card Electrophysiol       Date:  2019-08-09       Impact factor: 1.900

Review 2.  Cryoballoon ablation of atrial fibrillation: a practical and effective approach.

Authors:  George Georgiopoulos; Dimitris Tsiachris; Antonis S Manolis
Journal:  Clin Cardiol       Date:  2016-12-19       Impact factor: 2.882

3.  Transesophageal echocardiography guided transseptal puncture and nadir temperatures in cryoballoon pulmonary vein isolation.

Authors:  Christian Blockhaus; Hans-Peter Waibler; Jan-Erik Guelker; Heinrich Klues; Alexander Bufe; Melchior Seyfarth; Buelent Koektuerk; Dong-In Shin
Journal:  J Arrhythm       Date:  2022-02-04

4.  "Clinical Impact of the Cryoballoon Temperature and Occlusion Status on the Success of Pulmonary Vein Isolation".

Authors:  Takuro Nishimura; Kaoru Okishige; Yasuteru Yamauchi; Hideshi Aoyagi; Naruhiko Ito; Yusuke Tsuchiya; Takatoshi Shigeta; Rena Nakamura; Mitsutoshi Asano; Mitsumi Yamashita; Tomofumi Nakamura; Hidetoshi Suzuki; Tsukasa Shimura; Manabu Kurabayashi; Takehiko Keida; Tetsuo Sasano; Kenzo Hirao
Journal:  J Atr Fibrillation       Date:  2018-08-31

Review 5.  Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe Derived from Single Operator Experience and Review of the Literature.

Authors:  Antonis S Manolis
Journal:  Curr Cardiol Rev       Date:  2017
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.